Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07172347
PHASE2

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

View on ClinicalTrials.gov

Summary

This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study

Official title: A Multicenter, Randomized, Double-blind, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Non-segmental Vitiligo

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-10-31

Completion Date

2027-08-30

Last Updated

2026-01-02

Healthy Volunteers

No

Interventions

DRUG

VC005 tablets

VC005 groups repeat administration for 52 weeks

DRUG

VC005 Tablets Placebo

VC005 Placebo groups repeat administration for 52 weeks

Locations (1)

The Peking University People's Hospital

Beijing, Beijng, China